Increase in treatment of retinopathy of prematurity in the Netherlands from 2010 to 2017

Autor: Carlien A. M. Bennebroek, F.T. Kerkhoff, Frank A.M. van den Dungen, Robert P.G. Feenstra, Mark A. H. B. M. van der Hoeven, Cathrien A. Eggink, Elke Kraal‐Biezen, Wes Onland, Nicoline E. Schalij-Delfos, Enrico Lopriore, Floris Groenendaal, Laurentius J. van Rijn, Koen P. Dijkman, Noël J.C. Bauer, Kasia Trzcionkowska, Frank A B A Schuerman, Elsbeth S.M. Voskuil‐Kerkhof, Arno van Heijst, Ruben S G M Witlox, Huibert J. Simonsz, Victor W. Renardel de Lavalette, Peter H. Dijk, J.U.M. Termote, Wouter Vehmeijer, René F. Kornelisse
Přispěvatelé: Oogheelkunde, MUMC+: MA UECM Oogartsen MUMC (9), Kindergeneeskunde, RS: GROW - R4 - Reproductive and Perinatal Medicine, MUMC+: MA Medische Staf Kindergeneeskunde (9), Pediatrics, Ophthalmology, Graduate School, Neonatology, ARD - Amsterdam Reproduction and Development, Pediatric surgery, Amsterdam Reproduction & Development (AR&D)
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Male
Vascular Endothelial Growth Factor A
Pediatrics
Visual Acuity
Angiogenesis Inhibitors
Sensory disorders Donders Center for Medical Neuroscience [Radboudumc 12]
chemistry.chemical_compound
0302 clinical medicine
retinopathy of prematurity
Netherlands
OUTCOMES
Laser Coagulation
infants born
Absolute number
treatment
Incidence
Retinal detachment
Gestational age
Retinopathy of prematurity
General Medicine
Treatment characteristics
Bevacizumab
Intravitreal Injections
Original Article
Female
guideline
medicine.medical_specialty
laser photocoagulation
Birth weight
Gestational Age
03 medical and health sciences
medicine
Humans
Intravitreal bevacizumab
Retrospective Studies
business.industry
Infant
Newborn
Infant
Retinal
Original Articles
medicine.disease
eye diseases
Ophthalmology
chemistry
EXTREME
030221 ophthalmology & optometry
sense organs
business
oxygen
030217 neurology & neurosurgery
Follow-Up Studies
Zdroj: Acta Ophthalmologica (2008), 99, 1, pp. 97-103
Acta Ophthalmologica, 99(1), 97-103. Wiley
Acta Ophthalmologica, 99(1), 97-103. Wiley-Blackwell Publishing Ltd
Acta Ophthalmologica (2008), 99, 97-103
Acta Ophthalmologica
Acta ophthalmologica, 99(1), 97-103. Wiley
Acta Ophthalmologica, 99(1), 97-103. WILEY
Acta ophthalmologica, 99(1), 97-103. Copenhagen Scriptor
Acta Ophthalmologica, 99(1), 97-103. Wiley-Blackwell
Trzcionkowska, K, Vehmeijer, W B H J, Kerkhoff, F T, Bauer, N J C, Bennebroek, C A M, Dijk, P H, Dijkman, K P, van den Dungen, F A M, Eggink, C A, Feenstra, R P G, Groenendaal, F, van Heijst, A F, van der Hoeven, M A H B M, Kornelisse, R F, Kraal-Biezen, E, Lopriore, E, Onland, W, Renardel de Lavalette, V W, van Rijn, L J, Schuerman, F A B A, Simonsz, H J, Voskuil-Kerkhof, E S M, Witlox, R S G M, Termote, J U M & Schalij-Delfos, N E 2021, ' Increase in treatment of retinopathy of prematurity in the Netherlands from 2010 to 2017 ', Acta Ophthalmologica, vol. 99, no. 1, pp. 97-103 . https://doi.org/10.1111/aos.14501
ISSN: 1755-375X
Popis: Contains fulltext : 235444.pdf (Publisher’s version ) (Open Access) PURPOSE: Compare patients treated for Retinopathy of Prematurity (ROP) in two consecutive periods. METHODS: Retrospective inventory of anonymized neonatal and ophthalmological data of all patients treated for ROP from 2010 to 2017 in the Netherlands, subdivided in period (P)1: 1-1-2010 to 31-3-2013 and P2: 1-4-2013 to 31-12-2016. Treatment characteristics, adherence to early treatment for ROP (ETROP) criteria, outcome of treatment and changes in neonatal parameters and policy of care were compared. RESULTS: Overall 196 infants were included, 57 infants (113 eyes) in P1 and 139 (275 eyes) in P2, indicating a 2.1-fold increase in ROP treatment. No differences were found in mean gestational age (GA) (25.9 ± 1.7 versus 26.0 ± 1.7 weeks, p = 0.711), mean birth weight (791 ± 311 versus 764 ± 204 grams, p = 0.967) and other neonatal risk factors for ROP. In P2, the number of premature infants born
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje